A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment

被引:0
作者
Yin, Y. [1 ]
Tang, S. [2 ]
Shen, C. [1 ]
Zhang, B. [2 ]
机构
[1] West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-088
引用
收藏
页码:26 / 27
页数:2
相关论文
共 50 条
[31]   Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era [J].
Stiekema, Jurrien ;
Kol, Sabrine ;
Cats, Annemieke ;
Yazdi, Amir T. ;
van Coevorden, Frits ;
van Sandick, Johanna W. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (05) :502-507
[32]   Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors [J].
Nilsson, B. ;
Andersson, A. ;
Ahlman, H. .
JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (03) :145-146
[33]   Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors [J].
Ivanyi, Philipp ;
Eggers, Hendrik ;
Hornig, Mareike ;
Kasper, Bernd ;
Heissner, Klaus ;
Kopp, Hans-Georg ;
Kirstein, Martha ;
Ganser, Arnold ;
Grunwald, Viktor .
MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (06) :1-5
[34]   One institutional experience with imatinib mesylate in the treatment of gastrointestinal stromal tumors [J].
Tamas, Karin R. ;
Papai, Zsuzsa ;
Vegh, Eva A. ;
Petranyi, Agota E. ;
Szucs, Zoltan ;
Rohanszky, Magda ;
Aranyi, Zsuzsa ;
Bodoky, Gyorgy .
ANNALS OF ONCOLOGY, 2006, 17 :164-164
[35]   Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors? [J].
Peter Hohenberger .
Nature Clinical Practice Oncology, 2008, 5 :240-241
[36]   Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors [J].
César Serrano ;
Suzanne George ;
Claudia Valverde ;
David Olivares ;
Alfonso García-Valverde ;
Cristina Suárez ;
Rafael Morales-Barrera ;
Joan Carles .
Targeted Oncology, 2017, 12 :277-288
[37]   Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors [J].
Serrano, Cesar ;
George, Suzanne ;
Valverde, Claudia ;
Olivares, David ;
Garcia-Valverde, Alfonso ;
Suarez, Cristina ;
Morales-Barrera, Rafael ;
Carles, Joan .
TARGETED ONCOLOGY, 2017, 12 (03) :277-288
[38]   Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors [J].
Liu, Wei Zhen ;
Du, Yu Qiang ;
Shen, Qian ;
Tao, Kai Xiong ;
Zhang, Peng .
JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (9-10) :559-563
[39]   Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors [J].
Heger, U. ;
Weitz, J. ;
Lordick, F. .
CHIRURG, 2008, 79 (07) :630-637
[40]   Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors? [J].
Hohenberger, Peter .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (05) :240-241